Alterity Therapeutics (ATHE) Cash from Operations Growth (1y) (2010 - 2020)
Alterity Therapeutics (ATHE) Cash from Operations Growth (1y) (2010 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 60.84% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 85.14% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.72% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 74.39% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 3.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 36.76% |
| Dec 31, 2019 | 65.90% |
| Jun 30, 2019 | -20,575.33% |
| Dec 31, 2018 | -474.49% |
| Jun 30, 2018 | 98.93% |
| Dec 31, 2017 | -93.60% |
| Jun 30, 2017 | 20.46% |
| Jun 30, 2011 | -102,774,540.23% |
| Jun 30, 2010 | 32.67% |